R Gessa, A Tagliamonte, G L Gessa. Show Affiliations »
Abstract
Entities: Chemical Disease Species
Mesh: See more » AdultApomorphine/therapeutic useHaloperidol/adverse effectsHaloperidol/antagonists & inhibitorsHaloperidol/therapeutic useHumansMaleMovement Disorders/chemically inducedMovement Disorders/drug therapySchizophrenia/drug therapy
Substances: See more » HaloperidolApomorphine
Year: 1972 PMID: 4116875 DOI: 10.1016/s0140-6736(72)92525-1
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321